These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30920189)

  • 1. Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia.
    Lauriello J; Perkins DO
    J Clin Psychiatry; 2019 Mar; 80(2):. PubMed ID: 30920189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care.
    Lauriello J; Perkins DO
    J Clin Psychiatry; 2019 Feb; 80(1):. PubMed ID: 30786179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Addressing maladherence in schizophrenia].
    Vauth R
    Ther Umsch; 2018 Jun; 75(1):57-66. PubMed ID: 29909761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors for treatment adherence in patients with schizophrenia: case-control study].
    Aarab C; Elghazouani F; Aalouane R; Rammouz I
    Pan Afr Med J; 2015; 20():273. PubMed ID: 26161196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving treatment adherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In response to the Commentary to our systematic review 'Does adherence therapy improve medication adherence among patients with schizophrenia?'.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2015 Aug; 24(4):373-4. PubMed ID: 26245521
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication Adherence Decisions in Patients With Schizophrenia.
    Kikkert MJ; Dekker J
    Prim Care Companion CNS Disord; 2017 Dec; 19(6):. PubMed ID: 29216418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Samalin L; de Chazeron I; Blanc O; Brunel L; Fond G; Llorca PM
    Schizophr Res; 2016 Dec; 178(1-3):1-5. PubMed ID: 27637362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients.
    Tranulis C; Goff D; Henderson DC; Freudenreich O
    Psychiatr Serv; 2011 Aug; 62(8):888-92. PubMed ID: 21807827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
    Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
    Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
    Chang YT; Tao SG; Lu CL
    Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.
    Chien WT; Mui JH; Cheung EF; Gray R
    Trials; 2015 Jun; 16():270. PubMed ID: 26072311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment adherence in schizophrenia and schizoaffective disorder.
    Goff DC; Hill M; Freudenreich O
    J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is our clinical practice of antipsychotic relapse prevention in schizophrenia really evidence-based].
    Schanda H; Stompe T
    Neuropsychiatr; 2010; 24(1):14-26. PubMed ID: 20146916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS).
    Farooq S; Nazar Z; Irfan M; Akhter J; Gul E; Irfan U; Naeem F
    Br J Psychiatry; 2011 Dec; 199(6):467-72. PubMed ID: 22130748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2014 Dec; 23(6):490-7. PubMed ID: 25279684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving patient outcomes in schizophrenia: achieving remission, preventing relapse, and measuring success.
    Kane JM
    J Clin Psychiatry; 2013 Sep; 74(9):e18. PubMed ID: 24107769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The long-term treatment of schizophrenia].
    Herold R
    Orv Hetil; 2012 Jul; 153(26):1007-12. PubMed ID: 22735371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.